• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Cytokinetics, Incorporated (CYTK)

    6.91 Down 0.33(4.56%) 4:00PM EST
    |After Hours : 6.91 0.00 (0.00%) 4:57PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.8
    Mean Recommendation (last week):1.8

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:19.50
    Median Target:19.00
    High Target:24.00
    Low Target:15.00
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 4, 2014MLV & CoUpgradeHoldBuy
    Jul 2, 2012NeedhamInitiated Buy
    Oct 13, 2011Rodman & RenshawInitiated Mkt Outperform
    Nov 18, 2009Canaccord AdamsInitiated Buy
    Oct 29, 2009NeedhamDowngradeBuyHold
    Mar 31, 2009JMP SecuritiesInitiated Mkt Outperform
    Mar 20, 2009Wedbush MorganInitiated Buy
    Jul 19, 2007Credit SuisseInitiated Outperform
    Sep 6, 2006Needham & CoInitiated Buy
    Jun 30, 2006Cantor FitzgeraldUpgradeHoldBuy

    More Upgrades & Downgrades for CYTK

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111

    Data provided by Thomson/First Call

    Currency in USD.